Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Llewellyn Mills

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Drug and Alcohol Dependence|August 10, 2020
Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trialNicholas Lintzeris, Llewellyn Mills, Adrian Dunlop, et al.
Scientific Reports|February 18, 2026
The effect of daily aerobic cycling exercise on cannabis withdrawal: An inpatient randomised controlled trialLlewellyn Mills, Kieron Rooney, Danielle McCartney, et al.
Addiction (Abingdon, England)|November 17, 2020
Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populationsRachel M Deacon, Kristie Mammen, Raimondo Bruno, et al.
JMIR Research Protocols|February 11, 2022
The Essential Network (TEN): Protocol for an Implementation Study of a Digital-First Mental Health Solution for Australian Health Care Workers During COVID-19Matthew James Coleshill, Peter Baldwin, Melissa Black, et al.
Drug and Alcohol Review|September 14, 2021
Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, AustraliaNicholas Lintzeris, Rachel M Deacon, Victoria Hayes, et al.
Drug and Alcohol Review|April 20, 2022
The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptionsLauren A Monds, Maria Bravo, Llewellyn Mills, et al.
BMC Psychiatry|January 19, 2019
A cluster randomized controlled trial of an online psychoeducational intervention for people with a family history of depressionLlewellyn Mills, Bettina Meiser, Raghib Ahmad, et al.
The Medical Journal of Australia|July 14, 2023
Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort studyEmma Black, Raimondo Bruno, Kristie Mammen, et al.
Journal of Addiction Medicine|June 3, 2024
Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, AustraliaNathan Heijstee, Eleanor Black, Emma Black, et al.
Drug and Alcohol Review|December 16, 2022
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019Emma Black, Kristie Mammen, Rachel M Deacon, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Drug and Alcohol Dependence|August 10, 2020
Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trialNicholas Lintzeris, Llewellyn Mills, Adrian Dunlop, et al.
Scientific Reports|February 18, 2026
The effect of daily aerobic cycling exercise on cannabis withdrawal: An inpatient randomised controlled trialLlewellyn Mills, Kieron Rooney, Danielle McCartney, et al.
Addiction (Abingdon, England)|November 17, 2020
Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populationsRachel M Deacon, Kristie Mammen, Raimondo Bruno, et al.
JMIR Research Protocols|February 11, 2022
The Essential Network (TEN): Protocol for an Implementation Study of a Digital-First Mental Health Solution for Australian Health Care Workers During COVID-19Matthew James Coleshill, Peter Baldwin, Melissa Black, et al.
Drug and Alcohol Review|September 14, 2021
Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, AustraliaNicholas Lintzeris, Rachel M Deacon, Victoria Hayes, et al.
Drug and Alcohol Review|April 20, 2022
The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptionsLauren A Monds, Maria Bravo, Llewellyn Mills, et al.
BMC Psychiatry|January 19, 2019
A cluster randomized controlled trial of an online psychoeducational intervention for people with a family history of depressionLlewellyn Mills, Bettina Meiser, Raghib Ahmad, et al.
The Medical Journal of Australia|July 14, 2023
Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort studyEmma Black, Raimondo Bruno, Kristie Mammen, et al.
Journal of Addiction Medicine|June 3, 2024
Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, AustraliaNathan Heijstee, Eleanor Black, Emma Black, et al.
Drug and Alcohol Review|December 16, 2022
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019Emma Black, Kristie Mammen, Rachel M Deacon, et al.
Pageof 5